Disease | hyperthermia |
Comorbidity | C0376545|hematologic malignancy |
Sentences | 4 |
PubMedID- 21694894 | Long-term epidemiology of bacterial susceptibility profiles in adults suffering from febrile neutropenia with hematologic malignancy after antibiotic change. |
PubMedID- 21916097 | Background: the efficacy of conventional doses of piperacillin/ tazobactam (ptz) plus amikacin (amk) were compared retrospectively to low doses of cefepime (cef) plus amikacin in high risk febrile neutropenic patients with an underlying hematologic malignancy, and cef versus ptz (without amk) in low risk individuals with febrile neutropenia and underlying solid tumor malignancies. |
PubMedID- 20038242 | Awareness of this emerging syndrome and the usual causative agent is important to ensure appropriate management when febrile, neutropenic patients with hematologic malignancy exhibit signs of localized muscle infection. |
PubMedID- 26554923 | Background: invasive fungal disease (ifd) causes significant morbidity and mortality in hematologic malignancy patients with high-risk febrile neutropenia (fn). |
Page: 1